Related Experiment Videos
Apoptosis and melanoma chemoresistance
María S Soengas1, Scott W Lowe
1Department of Dermatology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 28109, USA. soengas@umich.edu
Abstract:
Melanoma is the most aggressive form of skin cancer and is notoriously resistant to all current modalities of cancer therapy. A large set of genetic, functional and biochemical studies suggest that melanoma cells become 'bullet proof' against a variety of chemotherapeutic drugs by exploiting their intrinsic resistance to apoptosis and by reprogramming their proliferation and survival pathways during melanoma progression. In recent years, the identification of molecules involved in the regulation and execution of apoptosis, and their alteration in melanoma, have provided new insights into the molecular basis for melanoma chemoresistance. With this knowledge in hand, the challenge is now to devise strategies potent enough to compensate or bypass these cell death defects and improve the actual poor prognosis of patients at late stages of the disease.
Insights
Melanoma cells resist chemotherapy by evading apoptosis and altering survival pathways. New strategies are needed to overcome these defects and improve patient outcomes for this aggressive skin cancer.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Melanoma is an aggressive skin cancer with high resistance to current therapies.
- Melanoma chemoresistance stems from resistance to apoptosis and altered proliferation/survival pathways.
- Understanding apoptosis regulation in melanoma is key to addressing treatment resistance.
Purpose of the Study:
- To investigate the molecular mechanisms underlying melanoma chemoresistance.
- To identify key molecules involved in apoptosis regulation and their alterations in melanoma.
- To explore strategies for overcoming cell death defects in advanced melanoma.
Main Methods:
- Genetic analysis of melanoma cell lines.
- Functional studies on apoptosis pathways.
- Biochemical assays to assess protein alterations.
- Review of recent literature on melanoma molecular biology.
Main Results:
- Melanoma cells exhibit intrinsic resistance to apoptosis.
- Reprogramming of proliferation and survival pathways contributes to chemoresistance.
- Specific molecular alterations in apoptosis pathways have been identified in melanoma.
Conclusions:
- Targeting apoptosis pathways is crucial for overcoming melanoma chemoresistance.
- Developing novel therapeutic strategies is essential to improve prognosis for advanced melanoma patients.
- Further research into molecular mechanisms can guide the development of more effective treatments.